Plant Polysaccharides in Alzheimer’s Disease: From Phytochemistry to Microbiota-Gut–Brain Axis Mechanisms—Resolving the Pharmacokinetic-Pharmacodynamic Paradox
Molecules · 28.07.2026 · 31 (15) · 2622
DOI: 10.3390/molecules31152622 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Molecules, online erschienen am 28.07.2026. Verfasst von Jie Gao und 4 weiteren Autor:innen. Beteiligte Einrichtung: Heilongjiang University of Chinese Medicine, Harbin 150040, China. Hauptthemen laut MEDLINE: Alzheimer Disease, Polysaccharides, Gastrointestinal Microbiome, Phytochemicals. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 118 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Heilongjiang Province Joint Fund Cultivation Project, Heilongjiang Postdoctoral Fund.
Themen: Demenz
Abstract (Originalsprache)
Alzheimer’s disease (AD) is a neurodegenerative disorder characterized by Aβ deposition, tau hyperphosphorylation, and neuroinflammation. No effective drugs can slow disease progression. Polysaccharides from traditional Chinese medicine (TCM) exhibit neuroprotective activities (e.g., antioxidant, anti-inflammatory) with good safety. However, their clinical application is limited by low oral bioavailability, poor blood–brain barrier (BBB) permeability, and a pharmacokinetic–pharmacodynamic paradox. The emerging role of the microbiota–gut–brain axis in AD offers a strategy to overcome this paradox. This review summarizes the structural features and classification of TCM polysaccharides (from plants, fungi, and roots/rhizomes) and highlights their anti-AD mechanisms via the gut–brain axis. Acting as prebiotics, these polysaccharides escape upper digestion and are fermented by gut microbiota into short-chain fatty acids (SCFAs) and other metabolites, which enter circulation, cross the BBB, and alleviate AD pathology through metabolic, immune, and neuronal pathways. Outcomes include reduced Aβ deposition and tau phosphorylation, suppressed neuroinflammation, restored synaptic function, and improved cognition. This review provides a theoretical framework for TCM polysaccharide intervention in AD via the gut–brain axis and a pharmacological basis for developing natural product-based AD therapies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Heilongjiang University of Chinese Medicine, Harbin 150040, China.
- Key Laboratory of Chinese Medicine Informatics of Heilongjiang Province, Harbin 150040, China.
ORCID-Profile: Jie Gao
Förderung
- National Natural Science Foundation of China
- Natural Science Foundation of Heilongjiang Province Joint Fund Cultivation Project
- Heilongjiang Postdoctoral Fund
- Heilongjiang Province Traditional Chinese Medicine Scientific Research Project
- Heilongjiang Provincial Postdoctoral Scientific Research Foundation
Zitieren
APA
Gao, J., Li, L., Liu, Q., Zhang, N., & Li, Y. (2026). Plant Polysaccharides in Alzheimer’s Disease: From Phytochemistry to Microbiota-Gut–Brain Axis Mechanisms—Resolving the Pharmacokinetic-Pharmacodynamic Paradox. Molecules, 31(15), 2622. https://doi.org/10.3390/molecules31152622
Vancouver
Gao J, Li L, Liu Q, Zhang N, Li Y. Plant Polysaccharides in Alzheimer’s Disease: From Phytochemistry to Microbiota-Gut–Brain Axis Mechanisms—Resolving the Pharmacokinetic-Pharmacodynamic Paradox. Molecules. 2026;31(15):2622. doi:10.3390/molecules31152622
BibTeX
@article{Gao2026,
author = {Gao, Jie and Li, Liheng and Liu, Qi and Zhang, Ning and Li, Yan},
title = {Plant Polysaccharides in Alzheimer’s Disease: From Phytochemistry to Microbiota-Gut–Brain Axis Mechanisms—Resolving the Pharmacokinetic-Pharmacodynamic Paradox},
journal = {Molecules},
year = {2026},
volume = {31},
number = {15},
pages = {2622},
doi = {10.3390/molecules31152622}
}
EUVIMED